Home › Companies › COGENT BIOSCIENCES INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and COGENT BIOSCIENCES INC.’s Form 8-K, filed June 5, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 4, 2025: 5 items on COGENT BIOSCIENCES INC.’s Form 8-K, filed June 5, 2025: 2 elected · 3 passed (calculated).
Significant dissent: 1 director (24.5% against).
Notable dissent: 1 director (14.8% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore COGENT BIOSCIENCES INC. in the interactive database Compare manager voting policies
These tallies are COGENT BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Karen Ferrante | 68,418,781 | -- | -- | 22,231,564 | 10,575,051 | 75% | Elected | — |
| Elect Director: Matthew E. Ros | 77,274,345 | -- | -- | 13,376,000 | 10,575,051 | 85% | Elected | — |
| 2. Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm | 101,115,649 | 104,268 | 5,479 | -- | 0 | 99.9% | Passed (calculated) | — |
| 3. Advisory Vote on Executive Compensation | 89,797,699 | 808,715 | 43,931 | -- | 10,575,051 | 99.1% | Passed (calculated) | — |
| 4. Approval of an Amendment to the Certificate of Incorporation to Provide for Officer Exculpation | 86,181,373 | 4,422,462 | 46,510 | -- | 10,575,051 | 95% | Passed (calculated) | — |
Source: COGENT BIOSCIENCES INC., Form 8-K, filed with the SEC on June 5, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
173 asset managers disclosed a vote on at least one COGENT BIOSCIENCES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Description as filed by funds: Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Karen Ferrante
COGENT BIOSCIENCES INC.’s own tally for this item (“Elect Director: Dr. Karen Ferrante”): 68,418,781 for, 22,231,564 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and each of the other proposals voted on were approved.”
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 27,824,681 for, 3,382,149 withheld, 216,053 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,608,699 | 0 | 0 | 293 | For |
| Vanguard | 5,988,543 | 0 | 0 | 0 | For |
| BlackRock | 3,807,657 | 0 | 0 | 0 | For |
| State Street | 4,669 | 0 | 0 | 1,823,414 | Withhold |
| Charles Schwab | 832,063 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 481,629 | Withhold |
| Dimensional | 0 | 0 | 0 | 278,589 | Withhold |
| Equitable | 164,570 | 0 | 0 | 82,060 | Mixed |
| TIAA | 230,900 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 230,000 | Withhold |
| Exchange Place Advisors Trust | 0 | 0 | 167,348 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 92,566 | Withhold |
| Tema ETF Trust | 72,370 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 70,578 | Withhold |
| Global X | 0 | 0 | 0 | 53,448 | Withhold |
| ProShares | 0 | 0 | 0 | 53,088 | Withhold |
| Northern Trust | 0 | 0 | 0 | 52,044 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 46,875 | Withhold |
| John Hancock | 0 | 0 | 34,042 | 0 | Abstain |
| Pacific Life | 29,922 | 0 | 0 | 0 | For |
| Nationwide | 25,837 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 25,323 | Withhold |
| T. Rowe Price | 21,774 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,600 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 14,737 | Withhold |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: Election of the two Class I director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Matthew E. Ros
COGENT BIOSCIENCES INC.’s own tally for this item (“Elect Director: Matthew E. Ros”): 77,274,345 for, 13,376,000 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “At the Annual Meeting, each of the Company's director nominees was elected and each of the other proposals voted on were approved.”
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 30,487,797 for, 878,597 withheld, 56,489 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,608,699 | 0 | 0 | 293 | For |
| Vanguard | 5,988,543 | 0 | 0 | 0 | For |
| BlackRock | 3,807,657 | 0 | 0 | 0 | For |
| State Street | 1,825,802 | 0 | 0 | 2,281 | For |
| Charles Schwab | 832,063 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 481,629 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 278,589 | Withhold |
| Equitable | 164,570 | 0 | 0 | 82,060 | Mixed |
| TIAA | 230,900 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 230,000 | Withhold |
| Exchange Place Advisors Trust | 159,221 | 0 | 8,127 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 92,566 | Withhold |
| Tema ETF Trust | 72,370 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,100 | 0 | 0 | 2,478 | For |
| Global X | 53,448 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 53,088 | Withhold |
| Northern Trust | 52,044 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 46,875 | Withhold |
| John Hancock | 0 | 0 | 34,042 | 0 | Abstain |
| Pacific Life | 29,922 | 0 | 0 | 0 | For |
| Nationwide | 25,837 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 0 | 25,323 | Withhold |
| T. Rowe Price | 21,774 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,600 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 14,737 | Withhold |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
95% Majority: yes · of votes cast
Description as filed by funds: APPROVAL OF AN AMENDMENT OF THE COMPANY'S CERTIFICATE OF INCORPORATION TO PROVIDE FOR OFFICER EXCULPATION.
COGENT BIOSCIENCES INC.’s own tally for this item (“4. Approval of an Amendment to the Certificate of Incorporation to Provide for Officer Exculpation”): 86,181,373 for, 4,422,462 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 30,710,800 for, 712,083 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,608,992 | 0 | 0 | 0 | For |
| Vanguard | 5,988,543 | 0 | 0 | 0 | For |
| BlackRock | 3,807,657 | 0 | 0 | 0 | For |
| State Street | 1,827,401 | 682 | 0 | 0 | For |
| Charles Schwab | 832,063 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 481,629 | 0 | 0 | Against |
| Dimensional | 278,589 | 0 | 0 | 0 | For |
| Equitable | 246,630 | 0 | 0 | 0 | For |
| TIAA | 230,900 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 230,000 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 8,127 | 159,221 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 92,566 | 0 | 0 | 0 | For |
| Tema ETF Trust | 72,370 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,578 | 0 | 0 | 0 | For |
| Global X | 0 | 53,448 | 0 | 0 | Against |
| ProShares | 53,088 | 0 | 0 | 0 | For |
| Northern Trust | 52,044 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 46,875 | 0 | 0 | 0 | For |
| John Hancock | 34,042 | 0 | 0 | 0 | For |
| Pacific Life | 29,922 | 0 | 0 | 0 | For |
| Nationwide | 23,077 | 2,760 | 0 | 0 | Mixed |
| Brighthouse | 25,323 | 0 | 0 | 0 | For |
| T. Rowe Price | 21,774 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,600 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 14,737 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Prior year: 91.2% for (June 5, 2024 meeting) ▲ 7.9 pts
Description as filed by funds: Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.
COGENT BIOSCIENCES INC.’s own tally for this item (“3. Advisory Vote on Executive Compensation”): 89,797,699 for, 808,715 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,608,992 | 0 | 0 | 0 | For |
| Vanguard | 5,988,543 | 0 | 0 | 0 | For |
| BlackRock | 3,807,657 | 0 | 0 | 0 | For |
| State Street | 1,827,562 | 521 | 0 | 0 | For |
| Charles Schwab | 832,063 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 481,629 | 0 | 0 | 0 | For |
| Dimensional | 278,589 | 0 | 0 | 0 | For |
| Equitable | 246,630 | 0 | 0 | 0 | For |
| TIAA | 230,900 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 230,000 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 167,348 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,566 | 0 | 0 | 0 | For |
| Tema ETF Trust | 72,370 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,578 | 0 | 0 | 0 | For |
| Global X | 53,448 | 0 | 0 | 0 | For |
| ProShares | 53,088 | 0 | 0 | 0 | For |
| Northern Trust | 52,044 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 46,875 | 0 | 0 | 0 | For |
| John Hancock | 34,042 | 0 | 0 | 0 | For |
| Pacific Life | 29,922 | 0 | 0 | 0 | For |
| Nationwide | 25,837 | 0 | 0 | 0 | For |
| Brighthouse | 25,323 | 0 | 0 | 0 | For |
| T. Rowe Price | 21,774 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,600 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 14,737 | 0 | 0 | 0 | For |
Fund voting reports, all 45 managers: 31,410,885 for, 11,998 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,801,728 | 0 | 0 | 0 | For |
| Paradigm Biocapital Advisors LP | 8,315,878 | 0 | 0 | 0 | For |
| Commodore Capital LP | 8,147,156 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 6,964,375 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 6,690,128 | Withhold |
| Fairmount Funds Management LLC | 6,225,641 | 0 | 0 | 0 | For |
| VR Adviser, LLC | 5,684,411 | 0 | 0 | 0 | For |
| State Street | 3,497,655 | 745 | 0 | 0 | For |
| BlackRock | 3,391,868 | 20,812 | 0 | 0 | For |
| Octagon Capital Advisors LP | 2,763,000 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2,640,214 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,405,646 | 0 | 0 | 0 | For |
| Redmile Group, LLC | 2,310,626 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 1,943,931 | 0 | 0 | 0 | For |
| Frazier Life Sciences Management, L.P. | 1,737,601 | 0 | 0 | 0 | For |
| Woodline Partners LP | 1,646,801 | 0 | 0 | 0 | For |
| Nantahala Capital Management, LLC | 1,497,387 | 0 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 1,431,770 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,326,382 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 1,122,471 | 0 | 0 | 0 | For |
| Charles Schwab | 834,771 | 0 | 0 | 0 | For |
| Northern Trust | 740,400 | 0 | 0 | 0 | For |
| Saturn V Capital Management LP | 665,306 | 0 | 0 | 0 | For |
| Point72 | 653,159 | 0 | 0 | 0 | For |
| Exome Asset Management LLC | 489,198 | 0 | 0 | 0 | For |
No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 99.9% for (June 5, 2024 meeting) unchanged
Description as filed by funds: Ratification of the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.
COGENT BIOSCIENCES INC.’s own tally for this item (“2. Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm”): 101,115,649 for, 104,268 against, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 31,422,171 for, 712 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 16,608,992 | 0 | 0 | 0 | For |
| Vanguard | 5,988,543 | 0 | 0 | 0 | For |
| BlackRock | 3,807,657 | 0 | 0 | 0 | For |
| State Street | 1,827,993 | 90 | 0 | 0 | For |
| Charles Schwab | 832,063 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 481,629 | 0 | 0 | 0 | For |
| Dimensional | 278,589 | 0 | 0 | 0 | For |
| Equitable | 246,630 | 0 | 0 | 0 | For |
| TIAA | 230,900 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 230,000 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 167,348 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 92,566 | 0 | 0 | 0 | For |
| Tema ETF Trust | 72,370 | 0 | 0 | 0 | For |
| Lincoln Financial | 70,578 | 0 | 0 | 0 | For |
| Global X | 53,448 | 0 | 0 | 0 | For |
| ProShares | 53,088 | 0 | 0 | 0 | For |
| Northern Trust | 52,044 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 46,875 | 0 | 0 | 0 | For |
| John Hancock | 34,042 | 0 | 0 | 0 | For |
| Pacific Life | 29,922 | 0 | 0 | 0 | For |
| Nationwide | 25,837 | 0 | 0 | 0 | For |
| Brighthouse | 25,323 | 0 | 0 | 0 | For |
| T. Rowe Price | 21,774 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 19,600 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 14,737 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. All 45 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 113,856,454 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.59% |
| 2 | Vanguard | 5.26% |
| 3 | BlackRock | 3.34% |
| 4 | State Street | 1.61% |
| 5 | Charles Schwab | 0.73% |
| 6 | FRANKLIN STRATEGIC SERIES | 0.42% |
| 7 | Dimensional | 0.24% |
| 8 | Equitable | 0.22% |
| 9 | TIAA | 0.20% |
| 10 | Delaware/Macquarie | 0.20% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.76% |
| 2 | Paradigm Biocapital Advisors LP | 7.30% |
| 3 | Commodore Capital LP | 7.16% |
| 4 | TCG Crossover Management, LLC | 6.12% |
| 5 | Kynam Capital Management, LP | 5.88% |
| 6 | Fairmount Funds Management LLC | 5.47% |
| 7 | VR Adviser, LLC | 4.99% |
| 8 | State Street | 3.07% |
| 9 | BlackRock | 3.00% |
| 10 | Octagon Capital Advisors LP | 2.43% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| FMR (Fidelity) | 17,077,329 | — | Form 13F, quarter ended March 31, 2025 |
| Entities affiliated with FMR LLC | 16,569,256 | — | Proxy statement (DEF 14A), proxy filed April 22, 2025 |
| Fairmount Funds Management LLC | 15,356,918 | — | Schedule 13D, filed March 31, 2026 |
| Entities affiliated with Fairmount Funds Management LLC | 11,825,641 | — | Proxy statement (DEF 14A), proxy filed April 22, 2025 |
| Entities affiliated with Commodore Capital LP | 10,497,990 | — | Proxy statement (DEF 14A), proxy filed April 22, 2025 |
| Entities affiliated with Point72 Asset Management, L.P. | 9,986,132 | — | Proxy statement (DEF 14A), proxy filed April 22, 2025 |
| Entities affiliated with Kynam Capital Management, LP | 9,239,731 | — | Proxy statement (DEF 14A), proxy filed April 22, 2025 |
| Deerfield Mgmt, L.P. | 9,043,903 | — | Schedule 13G, filed May 14, 2026 |
| BlackRock | 8,175,527 | — | Form 13F, quarter ended March 31, 2025 |
| Entities affiliated with TCG Crossover Fund I, L.P. | 6,964,375 | — | Proxy statement (DEF 14A), proxy filed April 22, 2025 |
Percentages above are of 113,856,454 shares outstanding, as reported by COGENT BIOSCIENCES INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At COGENT BIOSCIENCES INC.'s shareholder meeting held June 4, 2025, in the 2024-2025 proxy season, 173 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 935 separate fund positions. On the most widely held item on that ballot — Approval, on a non-binding, advisory basis, of the compensation of the Company's named… — FOR was 99.1% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: COGENT BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from COGENT BIOSCIENCES INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
COGENT BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “COGENT BIOSCIENCES (COGT) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/cogent-biosciences-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.